Compare IDYA & BTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | BTDR |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 2019 | 2021 |
| Metric | IDYA | BTDR |
|---|---|---|
| Price | $35.87 | $11.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 10 |
| Target Price | ★ $52.86 | $22.70 |
| AVG Volume (30 Days) | 1.4M | ★ 9.4M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $218,710,000.00 | N/A |
| Revenue This Year | N/A | $72.51 |
| Revenue Next Year | $201.05 | $40.84 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $21.33 | $7.04 |
| 52 Week High | $40.58 | $27.80 |
| Indicator | IDYA | BTDR |
|---|---|---|
| Relative Strength Index (RSI) | 50.34 | 32.01 |
| Support Level | $32.85 | $10.03 |
| Resistance Level | $38.17 | $12.86 |
| Average True Range (ATR) | 1.45 | 1.37 |
| MACD | -0.47 | -0.45 |
| Stochastic Oscillator | 4.70 | 0.00 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Bitdeer Technologies Group is principally engaged in the provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.